Literature DB >> 10430770

Interindividual heterogeneity in the hypoxic regulation of VEGF: significance for the development of the coronary artery collateral circulation.

A Schultz1, L Lavie, I Hochberg, R Beyar, T Stone, K Skorecki, P Lavie, A Roguin, A P Levy.   

Abstract

BACKGROUND: The coronary artery collateral circulation may be beneficial in protecting against myocardial ischemia and necrosis. However, there is a tremendous interindividual variability in the degree of new collateral formation in patients with coronary artery disease. The basis for this interindividual heterogeneity is not understood. In this study we test the hypothesis that failure to generate collateral vessels is associated with a failure to appropriately induce with hypoxia or ischemia the angiogenic factor, vascular endothelial growth factor (VEGF). METHODS AND
RESULTS: We correlated the VEGF response to hypoxia in the monocytes harvested from patients with coronary artery disease with the presence of collaterals visualized during routine angiography. We found that there was a highly significant difference in the hypoxic induction of VEGF in patients with no collaterals compared with patients with some collaterals (mean fold induction 1.9+/-0.2 versus 3.2+/-0.3, P<0.0001). After subjecting the data to ANCOVA, using as covariates a number of factors that might influence the amount of collateral formation (ie, age, sex, diabetes, smoking, hypercholesterolemia), patients with no collaterals still have a significantly lower hypoxic induction of VEGF than patients with collaterals.
CONCLUSIONS: This study provides evidence in support of the hypothesis that the ability to respond to progressive coronary artery stenosis is strongly associated with the ability to induce VEGF in response to hypoxia. The observed interindividual heterogeneity in this response may be due to environmental, epigenetic, or genetic causes. This interindividual heterogeneity may also help to explain the variable angiogenic responses seen in other conditions such as diabetic retinopathy and solid tumors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10430770     DOI: 10.1161/01.cir.100.5.547

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  47 in total

Review 1.  Surviving ischemia: adaptive responses mediated by hypoxia-inducible factor 1.

Authors:  G L Semenza
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

2.  Endocan: a novel biomarker associated with well-developed coronary collateral circulation in patients with stable angina and chronic total occlusion.

Authors:  Samim Emet; Ali Elitok; Imran Onur; Mehmet Kocaaga; Ahmet Kaya Bilge; Huseyin Oflaz; Berrin Umman; Aytac Oncul; Zehra Bugra; Kamil Adalet; Fehmi Mercanoglu
Journal:  J Thromb Thrombolysis       Date:  2017-01       Impact factor: 2.300

3.  Factors determining heterogeneity in coronary collateral development: A clinical perspective.

Authors:  Pier D Lambiase; Michael S Marber
Journal:  Exp Clin Cardiol       Date:  2002

Review 4.  Angiogenic growth factors in myocardial infarction: a critical appraisal.

Authors:  Hemalatha Thiagarajan; UmaMaheswari Thiyagamoorthy; Iswariya Shanmugham; Gunadharini Dharmalingam Nandagopal; Anbukkarasi Kaliyaperumal
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

5.  No association between polymorphism in the vascular endothelial growth factor gene at position -460 and sporadic prostate cancer in the Turkish population.

Authors:  Ilke H Onen; Ece Konac; Muzaffer Eroglu; Cagri Guneri; Hasan Biri; Abdullah Ekmekci
Journal:  Mol Biol Rep       Date:  2007-01-11       Impact factor: 2.316

6.  Association of genetic variants in VEGF-A with clinical recurrence in prostate cancer patients treated with definitive radiotherapy.

Authors:  T Langsenlehner; E-M Thurner; W Renner; A Gerger; K S Kapp; U Langsenlehner
Journal:  Strahlenther Onkol       Date:  2014-01-18       Impact factor: 3.621

7.  VEGFA SNP rs2010963 is associated with vascular toxicity in recurrent glioblastomas and longer response to bevacizumab.

Authors:  Anna Luisa Di Stefano; Marianne Labussiere; Giuseppe Lombardi; Marica Eoli; Donata Bianchessi; Francesco Pasqualetti; Patrizia Farina; Stefania Cuzzubbo; Jaime Gallego-Perez-Larraya; Blandine Boisselier; Francois Ducray; Caroline Cheneau; Arrigo Moglia; Gaetano Finocchiaro; Yannick Marie; Amithys Rahimian; Khe Hoang-Xuan; Jean Yves Delattre; Karima Mokhtari; Marc Sanson
Journal:  J Neurooncol       Date:  2014-12-07       Impact factor: 4.130

8.  Prognostic evaluation of VEGFA genotypes and haplotypes in a cohort of Brazilian women with non metastatic breast cancer.

Authors:  Hayra de Andrade Vieira-Monteiro; Daniely Regina Freitas-Alves; Marcelo Sobral-Leite; João Marcos de Azevedo Delou; Sheyla Maria Torres Goulart-Citrangulo; Camila Telles do Nascimento; Thales Nascimento E Castro; Sérgio Koifman; Jamila Alessandra Perini; Rosane Vianna-Jorge
Journal:  Cancer Biol Ther       Date:  2016-06-02       Impact factor: 4.742

Review 9.  Vascular repair by circulating endothelial progenitor cells: the missing link in atherosclerosis?

Authors:  Stefanie Dimmeler; Andreas M Zeiher
Journal:  J Mol Med (Berl)       Date:  2004-10       Impact factor: 4.599

Review 10.  Collateral circulation: past and present.

Authors:  Wolfgang Schaper
Journal:  Basic Res Cardiol       Date:  2008-12-20       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.